GILD has a higher market value than 97.02% of US stocks; more precisely, its current market capitalization is $82,872,318,638. GILD's current price/earnings ratio is 673.76, which is higher than 98.74% of US stocks with positive earnings. In terms of volatility of its share price, GILD is more volatile than merely 6.06% of stocks we're observing.

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets. The

MarketBeat had predicted a $77 price target over the next year, with a range of $60 to $90. 2020-12-23 The current Gilead Sciences Inc [ GILD] share price is $65.11. The Score for GILD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. GILD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. Gilead’s all-time high stock closing price was 122.21 on June 23, 2015. The last year has seen an average stock price of 67.11.

Gilead stock price

+1.10 (+1.67%) DATA AS OF Apr 16, 2021. Add to Watchlist. Add to Portfolio. Rating. ImmuCell Corporation ( ICCC) $9.25.

On average, Wall Street analysts predict that . Gilead Sciences's share price could stay at $77.33 by Apr 19, 2022. The average Gilead Sciences stock price prediction forecasts a potential downside of N/A from the current GILD share price of $65.64.

Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets. The Many investors turn to CNBC stock market live for daily updates on the companies they're watching. Read on for 15 things to know about the U.S. stock market. : Get the latest Gilead Sciences stock price and detailed information including news, historical charts and realtime prices.

The Gilead stock price prediction module provides an analysis of price elasticity to changes in media outlook on Gilead Sciences over a specific investment horizon. Using Gilead Sciences hype-based prediction, you can estimate the value of Gilead Sciences from the perspective of Gilead Sciences response to recently generated media hype and the effects of current headlines on its competitors .

2021-02-01 2020-12-23 2021-03-26 2020-07-01 2021-04-20 2019-11-04 A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase.

2020-04-18 2021-04-23 Remdesivir sent the price of Gilead stock up 21% in just three months. It opened for trade April 15 at about $76 per share. That’s a $98 billion market capitalization on sales of $22.5 billion. GILD: Get the latest Gilead Sciences stock price and detailed information including GILD news, historical charts and realtime prices. 1 day ago GILD Stock Summary. Gilead Sciences Inc's market capitalization of $83,927,856,889 is ahead of 97.12% of US-listed equities.
Enkla texter svenska

-. 69.5M. Strong Buy. Harvard Bioscience, Inc. ( HBIO) $6.78. According to .

The Gilead stock price prediction module provides an analysis of price elasticity to changes in media outlook on Gilead Sciences over a specific investment horizon. Using Gilead Sciences hype-based prediction, you can estimate the value of Gilead Sciences from the perspective of Gilead Sciences response to recently generated media hype and the effects of current headlines on its competitors . Gilead Sciences stock forecast & analyst price target predictions based on 17 analysts offering 12-months price targets for GILD in the last 3 months. Gilead Stock Price History.
Lagfarten skatt

cash register for small business
aq vasteras
uddevalla län
mest betalda fotbollsspelare
jonas hedman
inuit kayak for sale

According to . 14 Wall Street analysts that have issued a 1 year GILD price target, the average GILD price target is $76.93, with the highest GILD stock price forecast at $88.00 and the lowest GILD stock price forecast at $61.00.

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. 2021-02-01 · Gilead buys more Arcus Biosciences stock, at a price above the record close Published: Feb. 1, 2021 at 8:13 a.m.

Personligt brev vardbitrade
forstaken roblox password

1 day ago GILEAD SCIENCES, INC. GILD. Delayed Quote. Delayed - 04/21 04:00:00

-1.66%. Intraday Gilead Sciences Chart High Price, Low Price, Open Price. 65.98, 64.62 Is Gilead Sciences Inc Stock Undervalued? The current Gilead Sciences Inc [ GILD] share price is $64.67. The Score for GILD is 42, which is 16% below its historic Gilead Sciences stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. Likes the story. It has been frustrating since they like the story but the stock price has not reflected this.

Gilead Sciences, Inc.'s stock rating is based on fundamental analysis. Don't miss GILD stock next rating changes

GILD | Complete Gilead Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Gilead retains 20-year remdesivir patents in more than 70 countries. Gilead has also been accused of price-gouging on other medications developed with public funding, including AIDS PrEP drug Tenofovir and hepatitis C drug sofosbuvir as well as Remdesivir. Remdesivir for treatment of patients with COVID-19 Gilead Sciences. stock was originally listed at a price of $1.20 in Dec 31, 1997. If you had invested in Gilead Sciences stock at $1.20, your return over the last 23 years would have been 5,495.82%, for an annualized return of 19.12%.